Prior irradiation results in elevated programmed cell death protein 1 (PD-1) in T cells

被引:20
作者
Li, Deguan [1 ,2 ]
Chen, Renxiang [3 ]
Wang, Yi-Wen [3 ]
Fornace, Albert J., Jr. [3 ,4 ]
Li, Heng-Hong [3 ,4 ]
机构
[1] Chinese Acad Med Sci, Inst Radiat Med, Tianjin, Peoples R China
[2] Peking Union Med Coll, Tianjin, Peoples R China
[3] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA
[4] Georgetown Univ, Dept Oncol, Washington, DC 20057 USA
基金
中国国家自然科学基金;
关键词
Programmed cell death protein 1 (PD-1); ionizing radiation; T cells; checkpoint blockade; ANTITUMOR IMMUNITY; UP-REGULATION; RADIATION; CANCER; MICROENVIRONMENT; ACTIVATION; RESISTANCE; RESPONSES; EXPOSURE; OVERCOME;
D O I
10.1080/09553002.2017.1400192
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: In this study we addressed the question whether radiation-induced adverse effects on T cell activation are associated with alterations of T cell checkpoint receptors. Materials and methods: Expression levels of checkpoint receptors on T cell subpopulations were analyzed at multiple post-radiation time points ranging from one to four weeks in mice receiving a single fraction of 1 or 4 Gy of c-ray. T cell activation associated metabolic changes were assessed. Results: Our results showed that prior irradiation resulted in significant elevated expression of programmed cell death protein 1 (PD-1) in both CD4+ and CD8+ populations, at all three post-radiation time points. T cells with elevated PD-1 mostly were either central memory or naive cells. In addition, the feedback induction of PD-1 expression in activated T cells declined after radiation. Conclusion: Taken together, the elevated PD-1 level observed at weeks after radiation exposure is connected to T cell dysfunction. Recent preclinical and clinical studies have showed that a combination of radiotherapy and T cell checkpoint blockade immunotherapy including targeting the programmed death-ligand 1 (PD-L1)/PD-1 axis may potentiate the antitumor response. Understanding the dynamic changes in PD-1 levels in T cells after radiation should help in the development of a more effective therapeutic strategy.
引用
收藏
页码:488 / 494
页数:7
相关论文
共 50 条
  • [1] Programmed cell death protein 1 (PD-1) in infection
    Leth, Steffen
    Jensen-Fangel, Soren
    APMIS, 2020, 128 (02) : 177 - 187
  • [2] Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics
    Abaza, Abdelrahman
    Idris, Faten Sid
    Shaikh, Humna Anis
    Vahora, Ilma
    Moparthi, Kiran Prasad
    Al Rushaidi, Majdah T.
    Muddam, Meghana Reddy
    Obajeun, Omobolanle A.
    Jaramillo, Arturo P.
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [3] In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1)
    Reddy, Vishwanatha R. A. P.
    Mwangi, William
    Sadigh, Yashar
    Nair, Venugopal
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [4] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
    Matsuda, Kotaro
    Miyoshi, Hiroaki
    Hiraoka, Koji
    Hamada, Tetsuya
    Yoshida, Shiro
    Ishibashi, Yukinao
    Haraguchi, Toshiaki
    Shiba, Naoto
    Ohshima, Koichi
    CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
  • [5] The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
    Ness, Nora
    Andersen, Sigve
    Khanehkenari, Mehrdad Rakaee
    Nordbakken, Cecilie V.
    Valkov, Andrej
    Paulsen, Erna-Elise
    Nordby, Yngve
    Bremnes, Roy M.
    Donnem, Tom
    Busund, Lill-Tove
    Richardsen, Elin
    ONCOTARGET, 2017, 8 (16) : 26789 - 26801
  • [6] Programmed Cell Death Protein 1 (PD-1) in Relation to PANoptosis: Immune Pharmacological Targets for Management of Breast Adenocarcinoma
    Maitra, Subarnarekha
    Bhattacharya, Debarati
    Paul, Souvik
    Chowdhury, Payel Ghosh
    Mandal, Dipanjan
    Haldar, Pallab Kanti
    Balaraman, Ashok Kumar
    Bala, Asis
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (13) : 1571 - 1585
  • [7] Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes
    Okiyama, Naoko
    Katz, Stephen I.
    JOURNAL OF AUTOIMMUNITY, 2014, 53 : 1 - 9
  • [8] Inflammatory cytokines compromise programmed cell death-1(PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1
    Bommarito, D.
    Hall, C.
    Taams, L. S.
    Corrigall, V. M.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2017, 188 (03) : 455 - 466
  • [9] Programmed cell death protein-1 (PD-1)/programmed death-ligand-1 (PD-L1) axis in hepatocellular carcinoma: prognostic and therapeutic perspectives
    Mocan, T.
    Sparchez, Z.
    Craciun, R.
    Bora, C. N.
    Leucuta, D. C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (06) : 702 - 712
  • [10] Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells
    Mallett, Grace
    Laurence, Arian
    Amarnath, Shoba
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)